Profile for Canada Patent: 2879982
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: 2879982
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 9,085,553 | Jul 25, 2033 | Bausch And Lomb Inc | XIIDRA | lifitegrast |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
